153 related articles for article (PubMed ID: 11522873)
1. A prospective crossover trial comparing intermittent intravenous and continuous oral iron supplements in peritoneal dialysis patients.
Johnson DW; Herzig KA; Gissane R; Campbell SB; Hawley CM; Isbel NM
Nephrol Dial Transplant; 2001 Sep; 16(9):1879-84. PubMed ID: 11522873
[TBL] [Abstract][Full Text] [Related]
2. Oral versus intravenous iron supplementation in peritoneal dialysis patients.
Johnson DW; Herzig KA; Gissane R; Campbell SB; Hawley CM; Isbel NM
Perit Dial Int; 2001; 21 Suppl 3():S231-5. PubMed ID: 11887827
[TBL] [Abstract][Full Text] [Related]
3. Infusion of total dose iron versus oral iron supplementation in ambulatory peritoneal dialysis patients: a prospective, cross-over trial.
Ahsan N
Adv Perit Dial; 2000; 16():80-4. PubMed ID: 11045266
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled study of iron supplementation in patients treated with erythropoietin.
Macdougall IC; Tucker B; Thompson J; Tomson CR; Baker LR; Raine AE
Kidney Int; 1996 Nov; 50(5):1694-9. PubMed ID: 8914038
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of oral heme iron polypeptide versus oral iron supplementation for the treatment of anaemia in peritoneal dialysis patients: HEMATOCRIT trial.
Barraclough KA; Brown F; Hawley CM; Leary D; Noble E; Campbell SB; Isbel NM; Mudge DW; van Eps CL; Johnson DW
Nephrol Dial Transplant; 2012 Nov; 27(11):4146-53. PubMed ID: 22962411
[TBL] [Abstract][Full Text] [Related]
6. Effect of an intravenous iron dextran regimen on iron stores, hemoglobin, and erythropoietin requirements in hemodialysis patients.
Park L; Uhthoff T; Tierney M; Nadler S
Am J Kidney Dis; 1998 May; 31(5):835-40. PubMed ID: 9590194
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a low-dose intravenous iron sucrose regimen in peritoneal dialysis patients.
Dittrich E; Schillinger M; Sunder-Plassmann G; Hörl WH; Vychytil A
Perit Dial Int; 2002; 22(1):60-6. PubMed ID: 11929146
[TBL] [Abstract][Full Text] [Related]
8. Regular low-dose intravenous iron therapy improves response to erythropoietin in haemodialysis patients.
Taylor JE; Peat N; Porter C; Morgan AG
Nephrol Dial Transplant; 1996 Jun; 11(6):1079-83. PubMed ID: 8671972
[TBL] [Abstract][Full Text] [Related]
9. Oral vitamin C supplementation reduces erythropoietin requirement in hemodialysis patients with functional iron deficiency.
Sultana T; DeVita MV; Michelis MF
Int Urol Nephrol; 2016 Sep; 48(9):1519-24. PubMed ID: 27170339
[TBL] [Abstract][Full Text] [Related]
10. Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial).
Barraclough KA; Noble E; Leary D; Brown F; Hawley CM; Campbell SB; Isbel NM; Mudge DW; van Eps CL; Sturtevant JM; Johnson DW
BMC Nephrol; 2009 Jul; 10():20. PubMed ID: 19635169
[TBL] [Abstract][Full Text] [Related]
11. Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin requirement in iron-replete haemodialysis patients.
Schiesser D; Binet I; Tsinalis D; Dickenmann M; Keusch G; Schmidli M; Ambühl PM; Lüthi L; Wüthrich RP
Nephrol Dial Transplant; 2006 Oct; 21(10):2841-5. PubMed ID: 16891647
[TBL] [Abstract][Full Text] [Related]
12. Administration of the same dose of epoetin-beta intravenously and subcutaneously to patients with renal anaemia.
Steffensen GK; Stergaard O
Scand J Urol Nephrol; 2011 Dec; 45(6):461-9. PubMed ID: 21736448
[TBL] [Abstract][Full Text] [Related]
13. [Anemia in peritoneal dialysis patients].
Lausević M; Nesić V; Jovanović N; Stojimirović B
Srp Arh Celok Lek; 2006; 134(3-4):133-7. PubMed ID: 16915754
[TBL] [Abstract][Full Text] [Related]
14. Importance of iron supply for erythropoietin therapy.
Sunder-Plassmann G; Hörl WH
Nephrol Dial Transplant; 1995 Nov; 10(11):2070-6. PubMed ID: 8643170
[TBL] [Abstract][Full Text] [Related]
15. Iron status and iron supplementation in peritoneal dialysis patients.
Vychytil A; Haag-Weber M
Kidney Int Suppl; 1999 Mar; 69():S71-8. PubMed ID: 10084290
[TBL] [Abstract][Full Text] [Related]
16. Intravenous versus oral iron supplementation in peritoneal dialysis patients.
Johnson DW
Perit Dial Int; 2007 Jun; 27 Suppl 2():S255-60. PubMed ID: 17556315
[TBL] [Abstract][Full Text] [Related]
17. Iron supplementation in haemodialysis--practical clinical guidelines.
Silva J; Andrade S; Ventura H; Santos JP; Colaço S; Oliveira C; Ponce P
Nephrol Dial Transplant; 1998 Oct; 13(10):2572-7. PubMed ID: 9794562
[TBL] [Abstract][Full Text] [Related]
18. Haemoglobin response to subcutaneous versus intravenous epoetin alfa administration in iron-replete haemodialysis patients.
Leikis MJ; Kent AB; Becker GJ; McMahon LP
Nephrology (Carlton); 2004 Jun; 9(3):153-60. PubMed ID: 15189176
[TBL] [Abstract][Full Text] [Related]
19. Nomogram for individualizing supplementary iron doses during erythropoietin therapy in haemodialysis patients.
Kadota K; Kamata K; Kobayashi Y; Kagaya H; Shimada S; Yoshimoto-Furuie K; Echizen H
J Clin Pharm Ther; 2002 Apr; 27(2):111-9. PubMed ID: 11975695
[TBL] [Abstract][Full Text] [Related]
20. Effective utilization of erythropoietin with intravenous iron therapy.
Bhandari S; Brownjohn A; Turney J
J Clin Pharm Ther; 1998 Feb; 23(1):73-8. PubMed ID: 9756115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
